JP2009120598A5 - - Google Patents

Download PDF

Info

Publication number
JP2009120598A5
JP2009120598A5 JP2008273676A JP2008273676A JP2009120598A5 JP 2009120598 A5 JP2009120598 A5 JP 2009120598A5 JP 2008273676 A JP2008273676 A JP 2008273676A JP 2008273676 A JP2008273676 A JP 2008273676A JP 2009120598 A5 JP2009120598 A5 JP 2009120598A5
Authority
JP
Japan
Prior art keywords
group
pharmaceutically acceptable
solvate
acceptable salt
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008273676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009120598A (ja
JP4568779B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2008273676A priority Critical patent/JP4568779B2/ja
Priority claimed from JP2008273676A external-priority patent/JP4568779B2/ja
Publication of JP2009120598A publication Critical patent/JP2009120598A/ja
Publication of JP2009120598A5 publication Critical patent/JP2009120598A5/ja
Application granted granted Critical
Publication of JP4568779B2 publication Critical patent/JP4568779B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008273676A 2007-10-26 2008-10-24 スピロ環化合物及びその医薬用途 Expired - Fee Related JP4568779B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008273676A JP4568779B2 (ja) 2007-10-26 2008-10-24 スピロ環化合物及びその医薬用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007279697 2007-10-26
JP2008273676A JP4568779B2 (ja) 2007-10-26 2008-10-24 スピロ環化合物及びその医薬用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010165678A Division JP2010270137A (ja) 2007-10-26 2010-07-23 スピロ環化合物及びその医薬用途

Publications (3)

Publication Number Publication Date
JP2009120598A JP2009120598A (ja) 2009-06-04
JP2009120598A5 true JP2009120598A5 (https=) 2010-04-22
JP4568779B2 JP4568779B2 (ja) 2010-10-27

Family

ID=40579581

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2008273676A Expired - Fee Related JP4568779B2 (ja) 2007-10-26 2008-10-24 スピロ環化合物及びその医薬用途
JP2010165678A Pending JP2010270137A (ja) 2007-10-26 2010-07-23 スピロ環化合物及びその医薬用途
JP2014158380A Pending JP2014221829A (ja) 2007-10-26 2014-08-04 スピロ環化合物及びその医薬用途
JP2016001396A Ceased JP2016102130A (ja) 2007-10-26 2016-01-06 スピロ環化合物及びその医薬用途
JP2017049246A Pending JP2017132787A (ja) 2007-10-26 2017-03-14 スピロ環化合物及びその医薬用途

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2010165678A Pending JP2010270137A (ja) 2007-10-26 2010-07-23 スピロ環化合物及びその医薬用途
JP2014158380A Pending JP2014221829A (ja) 2007-10-26 2014-08-04 スピロ環化合物及びその医薬用途
JP2016001396A Ceased JP2016102130A (ja) 2007-10-26 2016-01-06 スピロ環化合物及びその医薬用途
JP2017049246A Pending JP2017132787A (ja) 2007-10-26 2017-03-14 スピロ環化合物及びその医薬用途

Country Status (29)

Country Link
US (3) US8299296B2 (https=)
EP (3) EP2684861A3 (https=)
JP (5) JP4568779B2 (https=)
KR (1) KR101565622B1 (https=)
CN (1) CN101835737B (https=)
AR (1) AR071055A1 (https=)
AU (1) AU2008314933B2 (https=)
BR (1) BRPI0818687A2 (https=)
CA (1) CA2704013C (https=)
CL (1) CL2008003153A1 (https=)
CO (1) CO6321230A2 (https=)
CY (1) CY1113352T1 (https=)
DK (1) DK2202216T3 (https=)
ES (1) ES2386596T3 (https=)
HR (1) HRP20120696T1 (https=)
IL (1) IL205283A (https=)
ME (1) ME02338B (https=)
MX (1) MX2010004435A (https=)
MY (1) MY148469A (https=)
NZ (1) NZ584161A (https=)
PE (1) PE20091014A1 (https=)
PL (1) PL2202216T3 (https=)
PT (1) PT2202216E (https=)
RS (1) RS52474B (https=)
RU (1) RU2490250C2 (https=)
SI (1) SI2202216T1 (https=)
TW (1) TWI421070B (https=)
WO (1) WO2009054479A1 (https=)
ZA (1) ZA201002305B (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2167621B1 (en) * 2007-06-11 2017-10-11 Givaudan SA Organic compounds as odorants
US8299296B2 (en) * 2007-10-26 2012-10-30 Japan Tobacco Inc. Spiro compounds and pharmaceutical use thereof
NZ588983A (en) * 2008-06-25 2011-11-25 Daiichi Sankyo Co Ltd Carboxylic acid compound
JP5749261B2 (ja) * 2009-06-29 2015-07-15 メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー ３，３，５，５−テトラメチルシクロヘキサノンを調製する方法
CA2765743A1 (en) 2009-06-29 2011-01-06 Merz Pharma Gmbh & Co. Kgaa Method of preparing 1-chloroacetamido-1,3,3,5,5-pentamethylcyclohexane
JP5738854B2 (ja) * 2009-06-29 2015-06-24 メルツ・ファルマ・ゲーエムベーハー・ウント・コ・カーゲーアーアー ネラメキサンの製造方法
EP2289881A1 (de) * 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen
AR078522A1 (es) * 2009-10-15 2011-11-16 Lilly Co Eli Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis
AR078948A1 (es) 2009-11-30 2011-12-14 Lilly Co Eli Compuestos de espiropiperidina, composicion farmaceutica que lo comprenden y su uso para preparar un medicamento util para tratar la diabetes
NZ601408A (en) 2009-12-25 2013-12-20 Mochida Pharm Co Ltd Novel 3-hydroxy-5-arylisothiazole derivative
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
JP5809157B2 (ja) 2010-10-08 2015-11-10 持田製薬株式会社 環状アミド誘導体
EA023573B1 (ru) 2011-02-01 2016-06-30 Бёрингер Ингельхайм Интернациональ Гмбх Дималеат 9-[4-(3-хлор-2-фторфениламино)-7-метоксихиназолин-6-илокси]-1,4-диазаспиро[5.5]ундекан-5-она, его применение в качестве лекарственного средства и его получение
BR112013027883A2 (pt) 2011-04-27 2017-08-08 Mochida Pharm Co Ltd novo derivado de 1-óxido de 3-hidroxiisotiazol
AU2012248627A1 (en) 2011-04-28 2013-11-14 Mochida Pharmaceutical Co., Ltd. Cyclic amide derivative
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
JP2015524400A (ja) 2012-07-19 2015-08-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ９−［４−（３−クロロ−２−フルオロ−フェニルアミノ）−７−メトキシ−キナゾリン−６−イルオキシ］−１，４−ジアザ−スピロ［５．５］ウンデカン−５−オンのフマル酸塩、その薬物としての使用及び調製
WO2014064215A1 (en) 2012-10-24 2014-05-01 INSERM (Institut National de la Santé et de la Recherche Médicale) TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL
TWI692469B (zh) 2012-11-09 2020-05-01 南韓商Ｌｇ化學股份有限公司 Ｇｐｒ４０受體促效劑，製造該促效劑的方法以及含有該促效劑作爲活性劑的醫藥組成物
WO2014078610A1 (en) 2012-11-16 2014-05-22 Bristol-Myers Squibb Company Dihydropyrazole gpr40 modulators
KR101569522B1 (ko) * 2013-04-18 2015-11-17 현대약품 주식회사 신규한 3-(4-(벤질옥시)페닐)헥스-4-이노익 산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물
EP3076959B1 (en) 2013-12-04 2018-07-04 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
EP3102198B1 (en) 2014-02-06 2020-08-26 Merck Sharp & Dohme Corp. Antidiabetic compounds
AU2015220427B2 (en) 2014-02-19 2017-09-21 Piramal Enterprises Limited Compounds for use as GPR120 agonists
WO2016012965A2 (en) 2014-07-25 2016-01-28 Piramal Enterprises Limited Substituted phenyl alkanoic acid compounds as gpr120 agonists and uses thereof
WO2016038540A1 (en) 2014-09-11 2016-03-17 Piramal Enterprises Limited Fused heterocyclic compounds as gpr120 agonists
US10426818B2 (en) 2015-03-24 2019-10-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method and pharmaceutical composition for use in the treatment of diabetes
JPWO2018181847A1 (ja) * 2017-03-31 2020-03-05 武田薬品工業株式会社 芳香環化合物
BR102018007822A2 (pt) 2017-04-20 2018-11-06 Gilead Sciences, Inc. composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição
TWI707849B (zh) 2018-02-13 2020-10-21 美商基利科學股份有限公司 Pd‐1/pd‐l1抑制劑
KR102591947B1 (ko) 2018-04-19 2023-10-25 길리애드 사이언시즈, 인코포레이티드 Pd-1/pd-l1 억제제
EP3820572B1 (en) 2018-07-13 2023-08-16 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
US11236085B2 (en) 2018-10-24 2022-02-01 Gilead Sciences, Inc. PD-1/PD-L1 inhibitors
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ，インク． Ｇｐｒ１１９アゴニスト
IL295825A (en) 2020-02-28 2022-10-01 Kallyope Inc gpr40 agonists
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators
CN115181023B (zh) * 2022-05-17 2023-07-28 东华理工大学 螺环活性增塑剂及其制备方法
CN121729216A (zh) * 2023-08-11 2026-03-24 生命密码有限公司 促进毛发生长和/或减轻脱发的组合物、药剂和制剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4331179A1 (de) * 1993-09-14 1995-03-16 Hoechst Schering Agrevo Gmbh Substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
GB9927056D0 (en) 1999-11-17 2000-01-12 Karobio Ab Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
ATE371008T1 (de) * 2002-10-14 2007-09-15 Firmenich & Cie Spiroverbindungen als duftstoffe
AU2003277576A1 (en) * 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
EP1630152A4 (en) * 2003-05-30 2009-09-23 Takeda Pharmaceutical CONDENSED CYCLIC COMPOUND
CA2547430A1 (en) * 2003-11-26 2005-06-09 Takeda Pharmaceutical Company Limited Receptor function regulating agent
AU2004309271A1 (en) * 2003-12-25 2005-07-14 Takeda Pharmaceutical Company Limited 3-(4-benzyloxyphenyl)propanoic acid derivatives
JP4074616B2 (ja) * 2003-12-25 2008-04-09 武田薬品工業株式会社 ３−（４−ベンジルオキシフェニル）プロパン酸誘導体
JP5299810B2 (ja) 2004-02-27 2013-09-25 アムジエン・インコーポレーテツド 代謝疾患の治療に使用するための、化合物、薬学的組成物及び方法
JP4859665B2 (ja) * 2004-03-30 2012-01-25 武田薬品工業株式会社 アルコキシフェニルプロパン酸誘導体
JP2007284350A (ja) * 2004-07-27 2007-11-01 Takeda Chem Ind Ltd 糖尿病治療剤
US7465804B2 (en) * 2005-05-20 2008-12-16 Amgen Inc. Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
WO2007033002A1 (en) * 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
CA2662305C (en) 2006-09-07 2012-04-17 Amgen Inc. Heterocyclic gpr40 modulators
AU2007292816B2 (en) * 2006-09-07 2011-11-17 Amgen Inc. Benzo-fused compounds for use in treating metabolic disorders
US8299296B2 (en) * 2007-10-26 2012-10-30 Japan Tobacco Inc. Spiro compounds and pharmaceutical use thereof
NZ588983A (en) 2008-06-25 2011-11-25 Daiichi Sankyo Co Ltd Carboxylic acid compound

Similar Documents

Publication Publication Date Title
JP2009120598A5 (https=)
RU2490250C2 (ru) Спиросоединения и их фармацевтическое применение
WO2007125405A3 (en) Substituted 2-amino-fused heterocyclic compounds
WO2009063202A3 (en) Use of crth2 antagonist compounds
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
NZ602754A (en) Substituted 1,3-benzothiazepines useful in treating metabolic disorders
JP2010524932A5 (https=)
JP2013510123A5 (https=)
EP1857457A3 (en) Benzimidazole derivative and its use as AII receptor antagonist
EP3404029A3 (en) Pyrimido-pyridazinone compounds and methods and use thereof
JP2018511647A5 (https=)
RU2009138600A (ru) Амиды диазабициклоалканов, селективные в отношении ацетилхолинового подтипа никотиновых рецепторов
PH12014502448A1 (en) Pharmaceutical combinations for the treatment of metabolic disorders
JP2014507477A5 (https=)
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
WO2011045232A3 (en) Neuropeptide-2 receptor (y-2r) agonists
WO2010052144A3 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
EA201391525A1 (ru) Гликозидные производные и их применение для лечения диабета
ATE528306T1 (de) Benzoxazepin-verbindungen, ihre herstellung und verwendung
MX2011013648A (es) Nuevos compuestos, composiciones farmaceuticas y metodos relacionados con ellos.
JP2013537240A5 (https=)
JP2017522304A5 (https=)
WO2008098978A3 (en) Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
RU2012150501A (ru) Противораковые стероидные лактоны, ненасыщенные в положении 7(8)
WO2014087307A3 (en) Compositions and methods for the treatment of metabolic syndrome and diabetes